Literature DB >> 24606468

Clinicopathological and p53 gene alteration comparison between young and older patients with gastric cancer.

Sajjad Karim1.   

Abstract

BACKGROUND: Differences in clinicopathological characteristics of gastric cancer (GC) between young and older patients are controversial and a matter of debate. Determining the statistical significance of clinicopathological information with respect to age might provide clues for better management and treatment of GC.
MATERIALS AND METHODS: A total of 103 Indian GC patients were enrolled for study and specimens were classified according to the AJCC-TNM system. Patients were grouped into two age-wise categories, young patients (<40 years; n=13) and older patients (≥40 years, n=90). The clinicopathological features of both groups were retrospectively examined and compared. p53 alterations were analyzed by polymerase chain reaction-single strand conformational polymorphism and immunohistochemistry methods at gene and protein levels respectively. The cases were considered p53 over-expressed if it was present in more than 25% of the tumor cells and p53 alterations was correlated with the clinicopathological characteristics of the patients as well as etiological factors for GC in both groups.
RESULTS: We found significant association of young patients with cancer stage (p=0.01), and very strong association with histology grade (p=0.064) and poorly differentiated (p=0.051) state of GC. However, neither young nor elderly patients showed associations with location, gender, etiological factors and p53 expression and alteration. Overall the male-to-female ratio of GC patients was 3.12 and the value was higher in the young (5.5) than in the older group (2.91).
CONCLUSIONS: Clinicopathological features of GC like cancer stage, cell differentiation and histological grades were significantly different among young and old age cohorts. We observed a male predominance among the young group that decreased significantly with advancing age. More awareness of GC onset is required to detect cancer at an early stage for successful treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24606468     DOI: 10.7314/apjcp.2014.15.3.1375

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy.

Authors:  Yadong Li; Jinsong Zhang
Journal:  Oncol Lett       Date:  2015-08-27       Impact factor: 2.967

2.  Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India.

Authors:  Shashikant C U Patne; V B Abhilash; Vinod Kumar Dixit; Richa Katiyar; Sandip Kumar; Gyan Prakash Singh
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 3.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

4.  Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects.

Authors:  Byoung-Chul Kim; Hyoung Oh Jeong; Daeui Park; Chul-Hong Kim; Eun Kyeong Lee; Dae Hyun Kim; Eunok Im; Nam Deuk Kim; Sunghoon Lee; Byung Pal Yu; Jong Bhak; Hae Young Chung
Journal:  Cancer Inform       Date:  2015-04-20

5.  Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.

Authors:  Fan Zhou; Yuanyuan Xu; Jiong Shi; Xing Lan; Xiaoping Zou; Lei Wang; Qin Huang
Journal:  Cancer Med       Date:  2016-10-25       Impact factor: 4.452

6.  Detection of gastric cancer and its histological type based on iodine concentration in spectral CT.

Authors:  Rui Li; Jing Li; Xiaopeng Wang; Pan Liang; Jianbo Gao
Journal:  Cancer Imaging       Date:  2018-11-09       Impact factor: 3.909

7.  Gastric Carcinomas in Young (Younger than 40 Years) Chinese Patients: Clinicopathology, Family History, and Postresection Survival.

Authors:  Fan Zhou; Jiong Shi; Cheng Fang; Xiaoping Zou; Qin Huang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.